157,817 Shares in Maximus, Inc. $MMS Bought by William Blair Investment Management LLC

Key Points

• William Blair Investment Management acquired 157,817 Maximus shares valued at approximately $8.5 million, representing about 0.30% of the company. Institutional investors collectively own 97.21% of Maximus.
• Maximus reported quarterly EPS of $2.22, narrowly beating estimates, while revenue of $1.28 billion fell short of expectations and declined 5.1% year over year. The company issued fiscal 2026 EPS guidance of $7.90–$8.20.
• Maximus declared a quarterly dividend of $0.33 per share, equal to an annualized $1.32 payout and a 2.3% yield. Analysts have a consensus “Reduce” rating after recent downgrades, with the stock trading near $58.29.

William Blair Investment Management LLC bought a new stake in shares of Maximus, Inc. (NYSE:MMS - Free Report) in the 2nd quarter, according to its most recent filing with the SEC. The institutional investor bought 157,817 shares of the health services provider's stock, valued at approximately $8,484,000. William Blair Investment Management LLC owned about 0.30% of Maximus at the end of the most recent quarter.

Several other large investors have also modified their holdings of the stock. Farther Finance Advisors LLC lifted its holdings in shares of Maximus by 69.0% in the 4th quarter. Farther Finance Advisors LLC now owns 284 shares of the health services provider's stock worth $25,000 after purchasing an additional 116 shares during the last quarter. Advisory Services Network LLC acquired a new position in shares of Maximus during the third quarter valued at $32,000. Northwestern Mutual Wealth Management Co. grew its position in shares of Maximus by 225.2% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 439 shares of the health services provider's stock worth $38,000 after acquiring an additional 304 shares during the last quarter. Canada Pension Plan Investment Board acquired a new stake in shares of Maximus in the 2nd quarter worth about $35,000. Finally, Danske Bank A S bought a new stake in Maximus in the 3rd quarter valued at about $55,000. Institutional investors own 97.21% of the company's stock.

Maximus Trading Up 0.1%

Maximus stock opened at $58.29 on Monday. Maximus, Inc. has a 12 month low of $52.73 and a 12 month high of $100.00. The company has a quick ratio of 2.42, a current ratio of 2.42 and a debt-to-equity ratio of 0.90. The stock has a market cap of $3.05 billion, a P/E ratio of 8.61 and a beta of 0.59. The company's fifty day simple moving average is $57.63 and its 200-day simple moving average is $64.39.

Maximus (NYSE:MMS - Get Free Report) last issued its earnings results on Thursday, August 6th. The health services provider reported $2.22 EPS for the quarter, beating analysts' consensus estimates of $2.21 by $0.01. The firm had revenue of $1.28 billion for the quarter, compared to the consensus estimate of $1.33 billion. Maximus had a return on equity of 24.91% and a net margin of 7.07%.The business's quarterly revenue was down 5.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.16 earnings per share. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. As a group, sell-side analysts forecast that Maximus, Inc. will post 8.01 EPS for the current fiscal year.

Maximus Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, August 31st. Stockholders of record on Friday, August 14th will be issued a dividend of $0.33 per share. The ex-dividend date is Friday, August 14th. This represents a $1.32 dividend on an annualized basis and a dividend yield of 2.3%. Maximus's payout ratio is presently 19.50%.

Analysts Set New Price Targets

Several research analysts have commented on the stock. Wall Street Zen cut shares of Maximus from a "buy" rating to a "hold" rating in a research report on Saturday, August 8th. Zacks Research downgraded Maximus from a "hold" rating to a "strong sell" rating in a research note on Tuesday, August 11th. Finally, Weiss Ratings reiterated a "hold (c-)" rating on shares of Maximus in a research report on Monday, August 17th. One equities research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Maximus has an average rating of "Reduce".

Maximus Profile

Maximus, Inc NYSE: MMS is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children's Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source